OBJECTIVE: To determine the effects of increasing dosages of continuously infused arginine-vasopressin (AVP) on mucosal tissue oxygen tension and oxygen supply in an auto-perfused, innervated jejunal segment in an acute endotoxic porcine model. DESIGN: Prospective, randomized, experimental study. SETTING: University hospital animal research laboratory. INTERVENTIONS: Jejunal mucosal tissue PO2 was measured employing two Clark-type surface oxygen electrodes. Oxygen saturation of jejunal microvascular hemoglobin was determined by tissue reflectance spectrophotometry. Systemic hemodynamic variables, mesenteric-venous and systemic acid base and blood gas variables and lactate measurements were recorded. Measurements were performed at baseline, after E. coli lipopolysaccharide (LPS) administration and at 20 min intervals during incremental AVP infusion (n=8; 0.014, 0.029, 0.057, 0.114 and 0.229 IU kg(-1) h(-1), respectively) or infusion of saline (n =8). MEASUREMENTS AND RESULTS: LPS infusion leads to a significant (P<0.05) decrease of mucosal tissue oxygen tension (PO2muc, 24+/-3 to 12+/-2 mmHg) and microvascular hemoglobin oxygen saturation (HbO2, 38+/-4 to 21+/-4%). Mesenteric venous lactate level increased (2.4+/-0.3 to 4.7+/-1.7 mmol l(-1)), while mesenteric venous pH decreased (7.38+/-0.02 to 7.26+/-0.12), indicating tissue hypoxia. AVP significantly increased mean arterial pressure (MAP, 81+/-15 to 97+/-17 at 0.057 IU kg(-1) h(-1)). No differences in jejunal mucosal oxygenation occurred between study groups at any dosage during the experimental protocol. CONCLUSION: AVP administration did not further compromise mucosal tissue oxygen tension and oxygen supply in the acute phase of endotoxic pigs.
OBJECTIVE: To determine the effects of increasing dosages of continuously infused arginine-vasopressin (AVP) on mucosal tissue oxygen tension and oxygen supply in an auto-perfused, innervated jejunal segment in an acute endotoxic porcine model. DESIGN: Prospective, randomized, experimental study. SETTING: University hospital animal research laboratory. INTERVENTIONS: Jejunal mucosal tissue PO2 was measured employing two Clark-type surface oxygen electrodes. Oxygen saturation of jejunal microvascular hemoglobin was determined by tissue reflectance spectrophotometry. Systemic hemodynamic variables, mesenteric-venous and systemic acid base and blood gas variables and lactate measurements were recorded. Measurements were performed at baseline, after E. colilipopolysaccharide (LPS) administration and at 20 min intervals during incremental AVP infusion (n=8; 0.014, 0.029, 0.057, 0.114 and 0.229 IU kg(-1) h(-1), respectively) or infusion of saline (n =8). MEASUREMENTS AND RESULTS:LPS infusion leads to a significant (P<0.05) decrease of mucosal tissue oxygen tension (PO2muc, 24+/-3 to 12+/-2 mmHg) and microvascular hemoglobin oxygen saturation (HbO2, 38+/-4 to 21+/-4%). Mesenteric venous lactate level increased (2.4+/-0.3 to 4.7+/-1.7 mmol l(-1)), while mesenteric venous pH decreased (7.38+/-0.02 to 7.26+/-0.12), indicating tissue hypoxia. AVP significantly increased mean arterial pressure (MAP, 81+/-15 to 97+/-17 at 0.057 IU kg(-1) h(-1)). No differences in jejunal mucosal oxygenation occurred between study groups at any dosage during the experimental protocol. CONCLUSION: AVP administration did not further compromise mucosal tissue oxygen tension and oxygen supply in the acute phase of endotoxic pigs.
Authors: H Knotzer; W Pajk; S Maier; R Ladurner; A Kleinsasser; V Wenzel; M W Dünser; H Ulmer; W R Hasibeder Journal: Am J Physiol Heart Circ Physiol Date: 2005-03-11 Impact factor: 4.733
Authors: Pierre Asfar; Marc Pierrot; Nary Veal; Frédéric Moal; Frédéric Oberti; Vincent Croquet; Olivier Douay; Yves Gallois; Jean-Louis Saumet; Philippe Alquier; Paul Calès Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Mary-Beth Malay; Jennifer L Ashton; Katherine Dahl; Edward B Savage; Sherryl A Burchell; Robert C Ashton; Robert R Sciacca; Juan A Oliver; Donald W Landry Journal: Crit Care Med Date: 2004-06 Impact factor: 7.598
Authors: Suzana M Lobo; Daniel De Backer; Qinghua Sun; Zizhi Tu; George Dimopoulos; Jean-Charles Preiser; Nathalie Nagy; Bernard Vray; Vincent Vercruy; Renato Giuseppe Giovanni Terzi; Jean-Louis Vincent; Zizi Tu Journal: J Appl Physiol (1985) Date: 2003-08-15
Authors: Martin Westphal; Hendrik Freise; Beate E Kehrel; Hans-Georg Bone; Hugo Van Aken; Andreas W Sielenkämper Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard Journal: Intensive Care Med Date: 2006-12-19 Impact factor: 17.440
Authors: Mengwei Ni; Jeffrey R Kaiser; Brady S Moffett; Christopher J Rhee; Jennifer Placencia; Kimberly L Dinh; Joseph L Hagan; Danielle R Rios Journal: J Pediatr Pharmacol Ther Date: 2017 Nov-Dec
Authors: Florian Simon; Ricardo Giudici; Angelika Scheuerle; Michael Gröger; Pierre Asfar; Josef A Vogt; Ulrich Wachter; Franz Ploner; Michael Georgieff; Peter Möller; Régent Laporte; Peter Radermacher; Enrico Calzia; Balázs Hauser Journal: Crit Care Date: 2009-07-10 Impact factor: 9.097
Authors: Lothar A Schwarte; Ingo Schwartges; Kai Thomas; Patrick Schober; Olaf Picker Journal: Intensive Care Med Date: 2011-03-05 Impact factor: 17.440